Voskens, C.J., Goldinger, S.M., Loquai, C., Robert, C., Kähler, K.C., Berking, C., Bergmann, T.R., Bockmeyer, C.L., Eigentler, T., Fluck, M., Garbe, C., Gutzmer, R., Grabbe, S., Hauschild, A., Hein, R., Hundorfean, G., Justich, A., Keller, U., Klein, C., Mateus, C., Mohr, P., Pätzold, S., Satzger, I., Schadendorf, D., Schlaeppi, M., Schuler, G., Schuler-Thurner, B., Trefzer, U., Ulrich, J., Vaubel, J., Moos, R. von, Weder, P., Wilhelm, T., Göppner, D., Dummer, R. und Heinzerling, L.M. (2013) „The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network“, PLOS ONE, (Band 8, Heft 1 (2013), Artikel-ID: e53745), S. , Heft 1 (2013), Artikel-ID: e53745. doi:10.1371/journal.pone.0053745.
Chicago Manual of Style 17th edition (full note)Voskens, Caroline J., Simone M. Goldinger, Carmen Loquai, Caroline Robert, Katharina C. Kähler, Carola Berking, Tanja Regina Bergmann, Clemens Luitpold Bockmeyer, Thomas Eigentler, Michael Fluck, Claus Garbe, Ralf Gutzmer, Stephan Grabbe, Axel Hauschild, Rüdiger Hein, Gheorghe Hundorfean, Armin Justich, Ullrich Keller, Christina Klein, Christine Mateus, Peter Mohr, Sylvie Pätzold, Imke Satzger, Dirk Schadendorf, Marc Schlaeppi, Gerold Schuler, Beatrice Schuler-Thurner, Uwe Trefzer, Jens Ulrich, Julia Vaubel, Roger von Moos, Patrik Weder, Tabea Wilhelm, Daniela Göppner, Reinhard Dummer, und Lucie M. Heinzerling. „The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network“. Electronic. PLOS ONE, Nr. Band 8, Heft 1 (2013), Artikel-ID: e53745 ([2013?]): , Heft 1 (2013), Artikel-ID: e53745. https://doi.org/10.1371/journal.pone.0053745.
American Psychological Association 7th editionVoskens, C. J., Goldinger, S. M., Loquai, C., Robert, C., Kähler, K. C., Berking, C., Bergmann, T. R., Bockmeyer, C. L., Eigentler, T., Fluck, M., Garbe, C., Gutzmer, R., Grabbe, S., Hauschild, A., Hein, R., Hundorfean, G., Justich, A., Keller, U., Klein, C., Mateus, C., Mohr, P., Pätzold, S., Satzger, I., Schadendorf, D., Schlaeppi, M., Schuler, G., Schuler-Thurner, B., Trefzer, U., Ulrich, J., Vaubel, J., Moos, R. von, Weder, P., Wilhelm, T., Göppner, D., Dummer, R., & Heinzerling, L. M. (ca. 2013). The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network [Electronic]. PLOS ONE, Band 8, Heft 1 (2013), Artikel-ID: e53745, , Heft 1 (2013), Artikel-ID: e53745. https://doi.org/10.1371/journal.pone.0053745
Modern Language Association 9th editionVoskens, C. J., S. M. Goldinger, C. Loquai, C. Robert, K. C. Kähler, C. Berking, T. R. Bergmann, C. L. Bockmeyer, T. Eigentler, M. Fluck, C. Garbe, R. Gutzmer, S. Grabbe, A. Hauschild, R. Hein, G. Hundorfean, A. Justich, U. Keller, C. Klein, C. Mateus, P. Mohr, S. Pätzold, I. Satzger, D. Schadendorf, M. Schlaeppi, G. Schuler, B. Schuler-Thurner, U. Trefzer, J. Ulrich, J. Vaubel, R. von Moos, P. Weder, T. Wilhelm, D. Göppner, R. Dummer, und L. M. Heinzerling. „The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network“. PLOS ONE, electronic, Nr. Band 8, Heft 1 (2013), Artikel-ID: e53745, Univ.-Bibliothek San Francisco, California, US : PLOS, 2006-, 2013, S. , Heft 1 (2013), Artikel-ID: e53745, https://doi.org/10.1371/journal.pone.0053745.
ISO-690 (author-date, Deutsch)VOSKENS, Caroline J., Simone M. GOLDINGER, Carmen LOQUAI, Caroline ROBERT, Katharina C. KÄHLER, Carola BERKING, Tanja Regina BERGMANN, Clemens Luitpold BOCKMEYER, Thomas EIGENTLER, Michael FLUCK, Claus GARBE, Ralf GUTZMER, Stephan GRABBE, Axel HAUSCHILD, Rüdiger HEIN, Gheorghe HUNDORFEAN, Armin JUSTICH, Ullrich KELLER, Christina KLEIN, Christine MATEUS, Peter MOHR, Sylvie PÄTZOLD, Imke SATZGER, Dirk SCHADENDORF, Marc SCHLAEPPI, Gerold SCHULER, Beatrice SCHULER-THURNER, Uwe TREFZER, Jens ULRICH, Julia VAUBEL, Roger von MOOS, Patrik WEDER, Tabea WILHELM, Daniela GÖPPNER, Reinhard DUMMER und Lucie M. HEINZERLING, 2013. The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLOS ONE. 2013. Nr. Band 8, Heft 1 (2013), Artikel-ID: e53745, S. , Heft 1 (2013), Artikel-ID: e53745. DOI 10.1371/journal.pone.0053745